BNP PARIBAS FINANCIAL MARKETS - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 152 filers reported holding KURA ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$494,769
-20.6%
54,251
-7.9%
0.00%0.0%
Q2 2023$623,490
-55.4%
58,931
-48.5%
0.00%
-50.0%
Q1 2023$1,399,418
+63.4%
114,425
+65.8%
0.00%
+100.0%
Q4 2022$856,464
-99.9%
69,014
-39.4%
0.00%
-50.0%
Q3 2022$1,555,519,000
+500.4%
113,874
+705.6%
0.00%
Q2 2022$259,095,000
-43.7%
14,135
-50.6%
0.00%
-100.0%
Q1 2022$459,824,000
-33.4%
28,596
-42.0%
0.00%0.0%
Q4 2021$690,116,000
-43.3%
49,294
-24.2%
0.00%
-50.0%
Q3 2021$1,217,637,000
+631.0%
65,010
+713.7%
0.00%
Q2 2021$166,571,000
-27.1%
7,989
-1.1%
0.00%
Q1 2021$228,337,000
-90.0%
8,077
-88.5%
0.00%
-100.0%
Q4 2020$2,289,891,000
+496.5%
70,113
+459.6%
0.00%
+300.0%
Q3 2020$383,889,000
+489.1%
12,529
+213.4%
0.00%
Q2 2020$65,167,000
-53.9%
3,998
-71.8%
0.00%
Q1 2020$141,210,000
+155.7%
14,192
+253.4%
0.00%
Q4 2019$55,220,000
-29.6%
4,016
-22.3%
0.00%
Q3 2019$78,429,000
+27.1%
5,170
+65.0%
0.00%
Q2 2019$61,708,000
-36.8%
3,134
-46.7%
0.00%
Q1 2019$97,566,000
+348350.0%
5,881
+293950.0%
0.00%
Q4 2018$28,000
-99.8%
2
-99.8%
0.00%
Q3 2018$15,050,000
-3.8%
8600.0%0.00%
Q2 2018$15,652,000
-83.2%
860
-82.7%
0.00%
Q1 2018$93,375,000
-92.9%
4,980
-94.2%
0.00%
-100.0%
Q4 2017$1,306,651,000
+6179.0%
85,402
+6035.2%
0.00%
Q3 2017$20,810,000
+49.7%
1,392
-6.9%
0.00%
Q2 2017$13,904,0001,4950.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 3,766,852$57,633,0006.49%
GREAT POINT PARTNERS LLC 2,197,283$33,618,0005.74%
Sio Capital Management, LLC 392,027$5,998,0003.38%
BVF INC/IL 1,353,846$20,714,0002.50%
Boxer Capital, LLC 844,789$12,925,0002.36%
ALETHEA CAPITAL MANAGEMENT, LLC 89,673$1,372,0002.18%
Minerva Advisors LLC 170,921$2,607,0001.41%
NEXTHERA CAPITAL LP 445,550$6,817,0001.26%
DAFNA Capital Management LLC 117,281$1,794,0000.97%
PFM Health Sciences, LP 1,752,124$26,807,0000.64%
View complete list of KURA ONCOLOGY INC shareholders